Use of pyrroloquinoline compounds to kill clinically latent microorganisms
US10493071B2 · kind B2 · utility
7Cited by
11References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2017 |
| Grant date | Dec 3, 2019 |
| Priority date | — |
| Expiry date | Jul 25, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided the use of compounds of formula I wherein R1, R2, R3 and X have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula I for treating microbial infections, as well as certain compounds of formula I per se.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.